Efficacy of first-line tocilizumab therapy in early polymyalgia rheumatica: a prospective longitudin...
Efficacy of first-line tocilizumab therapy in early polymyalgia rheumatica: a prospective longitudinal study
About this item
Full title
Author / Creator
Publisher
England: BMJ Publishing Group
Journal title
Language
English
Formats
Publication information
Publisher
England: BMJ Publishing Group
Subjects
More information
Scope and Contents
Contents
BackgroundGlucocorticoids are the cornerstone treatment of polymyalgia rheumatica (PMR) but induce adverse events.ObjectivesTo evaluate the efficacy and safety of first-line tocilizumab in PMR.MethodsIn a prospective open-label study (ClinicalTrials.gov: NCT01713842), 20 glucocorticoid-free patients fulfilling Chuang's PMR criteria, with symptom on...
Alternative Titles
Full title
Efficacy of first-line tocilizumab therapy in early polymyalgia rheumatica: a prospective longitudinal study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4975852
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4975852
Other Identifiers
ISSN
0003-4967
E-ISSN
1468-2060
DOI
10.1136/annrheumdis-2015-208742
